Debate begins over ethics of genetic editing
By Michael Cook,
BioEdge
| 12. 05. 2015
[cites CGS' Marcy Darnovsky and Pete Shanks]
Untitled Document
At the heart of the debate over the use of CRISPR technology for gene-editing is the human embryo. While manipulation of the genomes of plants and animals also raises profound ethical issues, it is the possibility of altering the human genome which generates summits and white papers.
So this week, there was a flurry of activity about the ethics of human genetic engineering.
At the International Summit on Human Gene-Editing in Washington DC this week, convoked by the US science and medicine academies, the UK Royal Society and the Chinese Academy of Sciences, it was apparent that little had changed since 12-round fight over the use of human embryonic stem cells a decade ago. Even the characters had not changed much; some, like George Q. Daley, of Harvard, and Robin Lovell-Badge, from the UK, were leading defenders of human embryonic stem cell research.
The summit concluded that “It would be irresponsible to proceed with any clinical use of germline editing unless and until (i) the relevant safety and efficacy issues have been resolved … and (ii) there is...
Related Articles
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...
By Neel Shah, The Preprint | 04.11.2024
Years ago, I interviewed for a residency position at The Johns Hopkins Hospital in Baltimore. Standing before the domed Victorian building at the campus entrance, I couldn’t help but be in awe of the history of the place, the great...
By Eleanor Hayward and Joanna Crawford, The Times | 03.29.2024
Gazing out at the Mediterranean from an idyllic rocky mountaintop, Sophie Hermann announced to her half a million Instagram followers that she had decided to freeze her eggs. Since that post in August, the 37-year-old former Made in Chelsea star...